Cancer Research UK logo.
SearchDonate
  • Search

A study of ulipristal acetate to prevent breast cancer (BC-APPS1)

Overview

Cancer types:

Breast cancer

Status:

Results

Phase:

Pilot

Details

This study looked at a drug called ulipristal acetate to prevent breast cancer for women who have an increased risk of developing it.

The study was open for people to join between 2016 and 2019. The team presented the results at a conference in 2023.

Ulipristal acetate is pronounced ul-pris-tal ass-e-tate.

Recruitment start: 15 March 2016

Recruitment end: 31 March 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Sacha Howell

Supported by

Breast Cancer Now

NIHR Clinical Research Network: Cancer

University Hospital of South Manchester (UHSM)

Last reviewed: 23 January 2025

CRUK internal database number: 13342

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.